Serum and Imaging Biomarkers for NASH Market Analysis (2026–2034)
The non-alcoholic steatohepatitis biomarkers market is an emerging and strategically important segment of the broader hepatology diagnostics, precision medicine, and clinical research ecosystem, centered on the identification and application of biological markers used to detect, monitor, and manage non-alcoholic steatohepatitis. This progressive liver condition, which develops from...